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Abstract
Many viruses depend on host microtubule motors to reach their destined intracellular location. Viral particles of neurotropic
alphaherpesviruses such as herpes simplex virus 1 (HSV1) show bidirectional transport towards the cell center as well as the
periphery, indicating that they utilize microtubule motors of opposing directionality. To understand the mechanisms of specific
motor recruitment, it is necessary to characterize the molecular composition of such motile viral structures. We have generated
HSV1 capsids with different surface features without impairing their overall architecture, and show that in a mammalian cell-free
system the microtubule motors dynein and kinesin-1 and the dynein cofactor dynactin could interact directly with capsids
independent of other host factors. The capsid composition and surface was analyzed with respect to 23 structural proteins that
are potentially exposed to the cytosol during virus assembly or cell entry. Many of these proteins belong to the tegument, the
hallmark of all herpesviruses located between the capsid and the viral envelope. Using immunoblots, quantitative mass
spectrometry and quantitative immunoelectron microscopy, we show that capsids exposing inner tegument proteins such as
pUS3, pUL36, pUL37, ICP0, pUL14, pUL16, and pUL21 recruited dynein, dynactin, kinesin-1 and kinesin-2. In contrast, neither
untegumented capsids exposing VP5, VP26, pUL17 and pUL25 nor capsids covered by outer tegument proteins such as vhs,
pUL11, ICP4, ICP34.5, VP11/12, VP13/14, VP16, VP22 or pUS11 bound microtubule motors. Our data suggest that HSV1 uses
different structural features of the inner tegument to recruit dynein or kinesin-1. Individual capsids simultaneously
accommodated motors of opposing directionality as well as several copies of the same motor. Thus, these associated motors
either engage in a tug-of-war or their activities are coordinately regulated to achieve net transport either to the nucleus during
cell entry or to cytoplasmic membranes for envelopment during assembly.
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Introduction
To reach their destined subcellular location, viruses utilize
motor proteins that move unidirectional along microtubules (MT)
or actin filaments [1,2,3,4,5]. Digital time-lapse microscopy
experiments in living cells have provided fundamental insights
into the dynamics of intracellular transport, and demonstrated that
host and viral cargos show rapid reversals in transport direction.
This raises the question how net transport towards a particular
destination is achieved and regulated. The cargo surface could
either engage exclusively inbound or outbound motors according
to the hypothesis of ‘‘exclusive presence’’, or the capsids could
recruit motors of opposing directionality simultaneously [6,7,8,9].
Two other scenarios could then enable net-transport despite the
simultaneous presence of different motors. According to the ‘‘tug-
of-war’’ hypothesis, each motor species moves the cargo towards
its own direction, and the net course is determined by those motors
exerting a stronger force than the opposition [10,11,12]. The
hypothesis of ‘‘coordinated regulation’’ proposes that the activity
of the bound motors is coordinately regulated so that they do not
interfere with each other [13,14,15].
Viral structures engage motors at different stages of the viral life
cycle [1,2,3,4]. Intracellular long distance motility such as axonal
transport requires a special subgroup of MT associated proteins
(MAPs), the MT motors. Cytoplasmic dynein, often in concert with
its cofactor dynactin, moves towards the minus-ends of MTs in the
cell center, while most kinesins propel towards MT plus-ends
pointing towards the plasma membrane and the presynaptic
terminals. These MAPs are built from multiple subunits derived
from several genes and alternative splice forms resulting in a
molecular weight of 1.5MD for dynein, 1.2MDfor dynactin, 340 to
380 kD for kinesin-1, and 260 to 280 kD for kinesin-2 [9,16,17,18].
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or indirect: viral proteins either bind to specific motor subunits, or
interact with membrane-associated and cytosolic adaptors to link to
such motors. Furthermore, viral particles are transported within
membranes that in turn recruit motors [3,5,8]. However, the protein
composition of motile viral particles is often unknown, and may even
change as the incoming viral genome is uncoated for transcription
and replication, or as progeny genomes are packaged into virions
[3,4,5]. Several interactions of motor subunits with viral proteins
have been identified, but could not be confirmed in the context of
native viral particles and functional motor complexes due to the lack
of appropriate biochemical assays [3,8]. Host proteins often show
altered affinities in isolation than after incorporation into protein
complexes. Dynein subunits, for example change their conformation
upon assembly into the motor, and thus their potential to interact
with putative cargo structures [19]. Furthermore, viral proteins are
often difficult to produce in soluble form since they have evolved to
self-assemble into higher ordered viral structures [20]. Their
structure may refold upon assembly into viral particles, and at
present, it is unclear which domains they expose to the cytosol.
Thus, there is a gap between studying the interactions of
individual host and viral proteins in isolation, and the analysis of
intracellular dynamics of viral and subviral structures in living
cells. One powerful approach for functional analysis is to
reconstitute a biological process from its components [21]. Yet,
few studies have characterized the association of viral particles
with cytosolic factors. Towards this end, we have developed cell-
free biochemical assays to analyze binding of viral capsids to MT
motors, capsid transport along MTs, capsid docking to nuclear
pore complexes, and viral genome uncoating [22,23]. For such
experiments, we use capsids from different stages of the life cycle of
herpes simplex virus type 1 (HSV1). Viral capsids purified from
HSV1 virions, but not nuclear capsids, that are isolated from
infected cells, recruit dynein and dynactin from Xenopus laevis
cytosol. Consistent with these data, the in vitro transport of HSV1
capsids along MTs requires ATP and cytosolic host factors [23].
HSV1 belongs to the alphaherpesviruses that establish lifelong
latent infections in sensory neurons after productive replication in
skin and mucosa, and that are actively transported within axons to
establish latency, after reactivation and during spread in the central
nervous system [2,24,25]. HSV1 is the causative agent of herpes
keratitis, the leading cause of blindness by infection, of herpes
encephalitis,a n do feczema herpeticum in patients with atopic dermatitis
[24]. The HSV1 virion is characterized by a non-centric localization
oftheicosahedralcapsidwithadiameterof125 nmthatcontainsthe
DNA genome. The capsid is covered by the tegument that on its
distal pole has a thickness of up to 35 nm, and by a viral envelope
[26]. Different HSV1 structures are transported within cells:
unenveloped cytosolic capsids, capsids within virions enclosed by
cellular membranes, and possibly also capsids attached to the
cytosolic face of host membranes [2,25,27,28,29,30]. Fluorescently
labeled particles of both HSV1 and pseudorabies virus (PrV), an
alphaherpesvirusofpig, show bidirectionaltransport towards the cell
center as well as the cell periphery with occasional, rapid reversals in
direction [29,31,32; Janus & Sodeik, in preparation].
After fusion of the HSV1 envelope with a host membrane, dynein
transportsincomingcytosoliccapsidsalongMTstowardsthenucleus
[26,33,34,35,36].Followingnuclearegress,progenycytosoliccapsids
acquire their envelope in the cytoplasm, and subsequently complete
mature virions inside membranes are transported to the plasma
membrane for exocytic egress [4,30,37,38]. HSV1 requires an intact
MTcytoskeleton for egressand spread, and axonal progenyparticles
co-localize with kinesin-1 [25,29,30,39,40]. However, the protein
composition of inbound or outbound viral particles is not known.
Cytosolic HSV1capsids could potentially useas many as 33different
capsid or tegument proteins to recruit MT motors that we have
classified into six groups (Table 1).
Here, we show that mammalian dynein, dynactin, kinesin-1 and
kinesin-2 were recruited to HSV1 capsids, and that dynein,
dynactin and kinesin-1 bound directly and independently of other
host proteins. We analyzed the protein composition and surface of
five different HSV1 capsid types with respect to 23 of the 33
structural HSV1 proteins potentially exposed to the cytosol. Our
data indicate that mammalian MAPs bound preferentially to
capsids that exposed inner tegument proteins such as pUS3,
pUL36, pUL37, ICP0, pUL14, pUL16 or pUL21 (pULX, protein
encoded by gene ULX on the unique long region of the HSV1
genome; pUSY, protein encoded by gene USY on the unique
short region). Neither untegumented nuclear capsids nor capsids
covered by outer tegument proteins bound to MAPs. Our data
suggest that dynein, dynactin and kinesin-1 use three different
inner tegument structural features to bind HSV1 capsids, and that
an individual capsid can simultaneously accommodate motors of
opposing polarity as well as several copies of the same motor.
Results
Probing the interaction of HSV1 capsids with cytosolic
host factors
To generate HSV1 particles that potentially bind host factors,
we extracted viral capsids with the non-ionic detergent TX-100 at
three different KCl concentrations (0.1, 0.5 or 1 M) from
extracellular particles, or isolated two different nuclear capsids
(B or C capsids) from infected cells (Fig. 1). The supernatant of
infected cells contains not only intact virions, but also unenveloped
capsids, membrane vesicles and exosomes as well as enveloped L
(light) particles containing HSV1 envelope and tegument but no
capsid proteins [41,42,43,44]. The viral particles sedimented from
the medium of infected cells were treated with trypsin to remove
potentially associated host factors, and subsequently with trypsin
inhibitor to inactivate the protease prior to the lysis of the virions
with detergent (c.f. Materials & Methods; Fig. S1).
As a source of mammalian proteins, we used cytosolic extracts of
pig brain that contain large amounts of MT motors. HSV1 capsids
Author Summary
Many viruses, particularly neurotropic alphaherpesviruses
such as herpes simplex virus (HSV), require an intact
microtubule network for efficient replication and patho-
genesis. In living cells, host and viral cargo show rapid
reversals in transport direction, suggesting that they can
recruit motors of opposing directionality simultaneously.
To elucidate the molecular mechanisms for specific motor-
cargo recognition, it is necessary to characterize the
surface of such cargos. We established a cell-free system
that reconstitutes the binding of native, mammalian
microtubule motors to intact tegumented HSV capsids.
Our data suggest that the inbound motor dynein and the
outbound motor kinesin-1 bind directly and independent-
ly of other host factors to the inner tegument that coats
the capsids during cytosolic transport. Identifying viral
receptors for the hosts’ transport machinery will provide us
on the one hand with new potential targets for antiviral
therapy. On the other hand, such viral protein domains
could be added to viral vectors or even to artificial nano
carriers designed to deliver therapeutic genes or mole-
cules to the nucleus or other subcellular destinations.
HSV1 Capsid Binding to Microtubule Motors
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sucrose cushions, and capsids with associated host proteins were
sedimented. Extracellular viral particles equivalent to about 5610
8
plaque-forming units (PFU) and treated with trypsin were required to
detect host proteins recruited from the cytosolic extract. Since each
capsid contains a high copy number of viral proteins (c.f.Table1), but
bound only few MAPs, the signals for host proteins were lower than
that for viral proteins which served as loading controls. As in the
Xenopus system [23], mammalian dynein and dynactin were co-
sedimented by HSV1 viral capsids from a cytosolic extract.
Distinct HSV1 capsids associate with specific MAPs
We then addressed which HSV1 capsids bind mammalian MT
motors. While nuclear B or C capsids do not contain tegument
Table 1. HSV1 proteins potentially interacting with cytosolic host factors.
HSV1 - structural protein Copies/Virion MW [kDa] Method of Analysis *
Capsid protein
VP5 (UL19) - hexon+penton 955 149 IB, MS
VP26 (UL35) - hexon surface 900 12 K/O, IB, MS
VP19c (UL38) - triplex 320 50 IB, MS
VP23 (UL18) - triplex 640 34 MS
VP24 (pUL26-N-term) 150 27 MS
Minor capsid-associated protein - required for DNA packaging
pUL6 - portal 12 74 IB
pUL17 40 75 IB, MS
pUL25 82 63 IB, MS, IEM
Inner tegument protein
pUS3 - protein kinase ? 53 K/O, IB, IEM
pUL36 - deubiquitinase 110–150 336 IB, MS, IEM
pUL37 (GFPUL37) 30–40 121 IB, MS, IEM
Tegument protein with enzymatic activity
pUL13 - protein kinase ? 57 -
pUL23 - thymidine kinase ? 41 -
pUL39 - ribonucleotide reductase subunit ? 124 -
pUL40 - ribonucleotide reductase subunit ? 38 -
vhs (virus host shut off protein, UL41) ? 55 IB
pUL50 - dUTPase ? 39 -
Other tegument protein
ICP0 (RL2) ? 79 IB
ICP4 (RS1) ? 133 IB
ICP34.5 (RL1) ? 26 IB
pUL7 ?3 3 -
pUL11 - myristylated ? 11 IB
pUL14 20–40 24 IB
pUL16 ? 40 IB, MS
pUL21 ? 58 MS
pUL51 ? 26 -
pUL55 ? 21 -
pUS2 - prenylated ? 33 -
pUS10 ? 34 -
Major tegument protein
VP11/12 (UL46) 410–1700 78 K/O, MS
VP13/14 (UL47) 1800 74 IB, MS, IEM
VP16 (UL48; aTIF) 1000–2000 54 IB, MS, IEM
VP22 (UL49) 1000–1500 32 IB, MS, IEM
pUS11 – binds RNA & ribosomes 600–1000 18 K/O, IB
The list of HSV1 structural proteins was compiled using several sources [23,24,30,37,45,64,98,99]: K/O, HSV1 deletion mutant; IB, immunoblot; MS, quantitative SILAC
mass spectrometry; IEM, quantitative immunoelectron microscopy.
doi:10.1371/journal.ppat.1000991.t001
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virions contain significant amounts of tegument [23,45]. With the
salt concentration increasing from 0.1 M KCl to 0.5 or even 1 M,
several major tegument proteins detach from the viral particles,
while inner tegument proteins continue to remain associated [23].
All 5 capsid types contained the major capsid proteins VP5, VP19c
and VP26 (Fig. 2A,B, VP: viral protein). The viral capsids (Fig. 2C)
had a morphology similar to nuclear C capsids as seen in electron
microscopy [46], suggesting that the tegument did not adsorb
further uranyl acetate that was used for negative contrasting.
We next analyzed the different capsids for their ability to
interact with mammalian factors. The MAPs dynein (Fig. 2A),
dynactin (Fig. 2A), kinesin-1 (Fig. 2B) and kinesin-2 (Fig. 2B)
bound to HSV1 viral capsids treated with 0.5 M KCl. While
kinesin-1 exhibited a remarkable binding preference for 0.5 M
KCl capsids, dynein, dynactin and kinesin-2 also showed a strong
affinity for capsids isolated at 1 M KCl. In contrast, tau, a non-
motor MAP, did not associate with any capsid type (Fig. 2B).
Nuclear B or C capsids neither bound dynein, dynactin, kinesin-1,
nor kinesin-2. Viral capsids extracted at 0.1 M KCl also recruited
only a few host factors. Moreover, recombinant GST or other
cytosolic proteins such as tau, amphiphysin-1, and LC3 also did
not bind to any of the capsids (not shown). Thus, some but not all
MAPs bound to a specific subset, but not to all HSV1 capsids.
Although we re-suspended the capsids by repeated tip
sonification and DNase and RNase treatment (Fig. 1), they may
oligomerize to different degrees that would reduce the accessible
capsid surface area. Therefore, we performed single capsid
analysis using electron microscopy. Nuclear capsids had a lower
propensity than viral capsids to associate with each other,
suggesting that the presence of tegument increased the affinity of
capsids for each other. All viral capsid preparations contained
many mono-dispersed capsids, but also some larger capsid
assemblies. However, the ratio of monomers to oligomers and
aggregates was independent of the applied KCl concentration
(data not shown). Since there was little oligomerization of nuclear
capsids, and that of viral capsids was independent of the tegument
composition, differences in MAP binding between different capsid
types were not caused by differences in capsid aggregation.
To study motor binding to individual particles, we adsorbed
capsids suspended in cytosol onto electron microscopy grids and
labeled them with antibodies against MAPs that in turn were
detected by protein A-conjugated colloidal gold (Fig. 1). Gold
particles co-localizing with mono-disperse capsids were counted
to quantify the amount of host factors per capsid (Fig. 2C). To
exclude an overestimation based on aggregated gold associated
with only one antigen or on multiple gold labels on the multiple
subunits of a single motor complex [33,47] multiple gold particles
less than 40 nm apart were only scored as one label (Fig. 2C;
circles on the capsid drawing represented two labeling events,
whereas the stars were recorded as one label). The average
number of gold particles on capsids that had been incubated with
buffer instead of cytosolic proteins was considered background
and subtracted. Capsids treated with 0.5 M KCl had 0.75 gold/
capsid above background after labeling for dynein and dynactin,
and 0.5 gold/capsid for kinesin-1 and kinesin-2 (Fig. 2D).
Consistent with the immunoblot data, the affinity of dynein for
0.5 M KCl capsids was as strong as for 1 M KCl capsids, whereas
0.1 M KCl and nuclear capsids recruited little dynein. Binding of
dynactin and kinesin-2 was similar to that of dynein, but there
was less binding to 1 M than to 0.5 M KCl capsids. In contrast,
kinesin-1 was most prominently detected on capsids extracted at
0.5 M KCl, whereas all other capsid types had recruited very
little kinesin-1.
For further assessment, we normalized the results of the
immunoblot and the immunoelectron microscopy for the viral
capsids such that the amount of a given MAP on the capsids with
the highest amount was set to 100%, and the other data
recalculated accordingly (Fig. 3, left 4 data sets; Supplementary
Table S1). The quantitative single-particle analysis confirmed that
the minor differences in capsid aggregation did not account for the
specificity of MAP binding to HSV1 capsids. All MAPs
preferentially bound to capsids that had been extracted with high
KCl concentrations, but not to nuclear, un-tegumented capsids, or
to 0.1 M KCl capsids containing the highest amount of tegument
proteins. Overall, the viral capsids treated with 0.5 M KCl
treatment provided the best substrate for MAP binding.
Several motors can bind to one HSV1 capsid
The electron microscopy analysis prompted us to ask whether a
viral capsid treated with 0.5 M KCl could bind several copies of a
MAP simultaneously. In a two-dimensional projection, icosahedral
capsids appear as hexagons that we divided into six segments
(Fig. 2C, capsid drawing). We then counted the number of capsids
that had labels on 0, 1, 2, or more of such segments as a means for
the potential presence of several host factors per capsid. We never
detected labeling on 5 or all 6 segments (Fig. 2E). There were two
labels for dynein on about 40% of the capsids, for dynactin on
25%, for kinesin-1 on 20% and for kinesin-2 on 8%. There were
also a few capsids with even three labels for dynein, dynactin, or
kinesin-1. Taking the background labeling into account (about one
gold on every second or third capsid), these data suggest that we
could detect at least more than one complex of dynein on about
20%, and more than one dynactin and kinesin-1 on about 10% of
the capsids.
Dynein, dynactin, and kinesin-1 bind directly to HSV1
capsids
Transport of cellular cargo often requires adaptors to link the
cargo to its motor [6,9,17]. To test whether MAP binding required
additional factors, we incubated capsids with purified motor
complexes. Native dynein, dynactin, or kinesin-1 bound directly to
0.5 M KCl viral capsids, but not to nuclear capsids (Fig. 4). When
we applied dynein and dynactin together, there was neither a
synergistic increase nor a reduction in binding of these MAPs to
the viral capsids. Thus, dynactin was not required to recruit
dynein to HSV1 capsids. In addition, dynein and dynactin did not
seem to compete for the same capsid binding sites. These data
show that no further host adaptors were required for recruiting
dynein, dynactin, or kinesin-1 to HSV1 viral capsids.
Figure 1. Analysis of host factor recruitment to HSV1 capsids. Partially tegumented viral capsids were generated from mature extracellular
particles released from HSV1 infected cells by detergent lysis to remove the viral envelope in the presence of 0.1 M, 0.5 M or 1 M KCl to extract
different amounts of tegument (light green), and purified through sucrose cushions. Untegumented nuclear B and C capsids (dark green) were
isolated from the nuclei of HSV1 infected cells by gradient sedimentation. The 5 different capsid types were resuspended in BRB80 buffer using tip
sonification, treated with DNase and RNase, repelleted, and then incubated with cytosolic extracts or purified MAPs (colored circles). Capsids were
analyzed for bound host factors either after sedimentation through a sucrose cushion by immunoblot or directly by electron microscopy after
immunolabeling and negative contrasting.
doi:10.1371/journal.ppat.1000991.g001
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PLoS Pathogens | www.plospathogens.org 5 July 2010 | Volume 6 | Issue 7 | e1000991Figure 2. Plus- and minus-end directed MT motors bind to HSV1 capsids. A and B: Immunoblot analysis of MAP binding to capsids. HSV1(F)
viral (0.5 M KCl, lanes 1 and 3; 0.1 M KCl, lanes 2; 1 M KCl, lanes 4) or nuclear capsids (C capsids, lanes 5; B capsids, lanes 6) or mock samples lacking
capsids (lanes 7) were incubated in 0.25 mg/ml (A, lanes 2 to 7) or 0.75 (B; lanes 2 to 7) mg/ml pig brain cytosol, and sedimented through sucrose
cushions. The host proteins were analyzed by immunoblot using antibodies against dynein (A: MAB1618 against intermediate chain; pAb anti-LIC2
against light intermediate chain), and dynactin (A: mAb anti-p50), or kinesin-1 (B: MAB1613 against heavy chain), kinesin-2 (B: mAb against KAP3A)
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pUS11, or VP11/12
Several HSV1 proteins have been implicated in intracellular
transport. The major capsid protein VP26 can directly interact
with dynein light chains [48], and the major tegument protein
pUS11 with kinesin-1 heavy chain (KIF5B) as well as the MT-
binding protein PAT1 [49,50]. We therefore generated capsids
from HSV1 mutants lacking VP26, pUS11, or VP11/12 as
another major tegument protein, and tested them for their ability
to interact with MAPs. Dynein, dynactin and kinesin-1 bound viral
capsids lacking VP26, pUS11, or VP11/12 but not the
corresponding nuclear capsids (Fig. 5) indicating that the
preference of MAP binding to tegumented capsids over untegu-
mented ones was not due to these HSV proteins. Interestingly, in
the absence of VP11/12, the MAPs bound with even higher
efficiency. Thus, abundant tegument proteins such as VP11/12, or
other proteins that require VP11/12 for binding to capsids, might
prevent or reduce access to potential MAP receptors on the surface
of the HSV1 capsids.
Protein composition of nuclear and viral HSV1 capsids
Next, we characterized the protein composition of the capsids.
Our previous study has shown that major tegument proteins
remain attached to viral capsids prepared at 0.1 M KCl, but are
extracted with 0.5 M KCl; however, back then we detected no
differences between 0.5 and 1 M KCl capsids [23]. Yet, 0.5 M
KCl capsids bound kinesin-1 whereas those treated with 1 M did
not. We therefore extended our initial immunoblot analysis, and
performed quantitative mass spectrometry using stable isotope
labeling with amino acids in cell culture (SILAC) [51] of (i) virions
purified on linear nycodenz gradients (GP in Fig. 6 and 7), (ii)
nuclear B capsids, (iii) nuclear C capsids, (iv) 1 M KCl viral
capsids, (v), 0.5 M KCl viral capsids, (vi) 0.1 M KCl capsids, and
(vi) trypsin-treated extracellular particles (MP for medium pellet),
the starting material for preparation of viral capsids. We could
thus analyze 23 of the 33 HSV1 proteins potentially exposed to
cytosolic host proteins.
In addition to the specific proteins of interest, all blots were
probed for the capsid proteins VP5 and VP26 as loading controls
(Fig. 6). For mass spectrometry, each sample was mixed with
deuterated gradient purified virions (GP in Fig. 7), and the relative
concentration of proteins were determined from the ratio of
deuterated (set to 100%) to undeuterated peptide peaks. If a capsid
population contained less of a given protein than gradient purified
virions, its value was below 100%. For standardization, the
amount of VP5 in all capsid types was normalized to 100% [52],
and the concentrations of the other HSV1 proteins were re-
calculated accordingly (Fig. 7). When compared to the loading
control VP5, all capsid types contained similar amounts of the
capsid proteins VP19c, VP23, and VP24. While mass spectrom-
etry indicated similar amounts of VP26 (Fig. 7A), the immunoblots
showed a lower signal on nuclear than on viral capsids possibly
suggesting an antibody preference for a mature form of VP26
(Fig. 6A–E). As reported before [53,54], there were less pUL17
and pUL25 on B than on other capsid types (Fig. 6B,C).
The inner tegument proteins pUS3, pUL36, and pUL37 were
present in similar amounts on viral, but absent from nuclear
capsids. Compared to gradient purified virions, viral capsids
contained less pUL36 and pUL37 (Fig. 6A,B; 7B), and
interestingly, during capsid preparation, the amount of a 220 kD
N-terminal fragment of pUL36 (residues 1 to about 2500; Fig. 6B)
increased as full-length pUL36 decreased. A similar pUL36
fragment has also been detected in PrV virions [55]. An antibody
directed against a middle portion of pUL36 (residues 1408–2112)
detected numerous fragments of pUL36 (Fig. 6B), and Coomassie
gels revealed two prominent bands of 270 and 220 kD (not
shown). In addition, the HSV1 proteins ICP0, pUL14, pUL16,
and pUL21 were present on viral capsids in similar amounts, with
the lowest concentration on 1 M KCl capsids, but absent from
nuclear capsids (Fig. 6C,D; 7C).
Nuclear capsids also lacked the major tegument proteins VP13/
14, VP16, VP22, pUS11 and pUL11, but in contrast to inner
tegument proteins, the concentration of these proteins was lowered
with increasing KCl concentrations from 0.1 to 1 M KCl
(Fig. 6A,B,D,E). Surprisingly, there was more VP11/12 in
extracellular particles and viral capsids than in gradient-purified
virions (Fig. 7C). The medium pellet also contained a higher
proportion of pUL17, pUL36, pUL37, pUL21, VP13/14, VP16
and VP22 than gradient purified virions. This large amount of
tegument proteins may originate from extracellular L particles that
have a similar morphology as virions but lack capsids [41].
Tegument proteins derived from L particles, particularly VP11/
12, might have associated with capsids during the lysis of the
extracellular particles. vhs, ICP4, and ICP34.5 were also - in
addition to VP13/14, VP16, VP22, pUL11, and VP11/12 -
gradually detached from the viral capsids with increasing KCl
amounts, but not detected on nuclear capsids (Fig. 6C,D,E).
For further assessment, we set the amount of a given tegument
protein on the capsids with the highest amount to 100%, and
recalculated the other data accordingly (Fig. 3; immunoblot, white
columns; mass spectrometry, green columns; Supplementary
Table S1). In summary, nuclear capsids that do not bind MAPs
contained very little tegument. With salt concentrations increasing
from 0.1 to 0.5 M KCl, major and many other tegument proteins
were removed from the viral capsids, and the capsids bound better
to MAPs. All viral capsids contained the inner tegument proteins
pUS3, pUL36, an N-terminal fragment of pUL36, and pUL37, as
well as ICP0, pUL14, pUL16, and pUL21 in similar amounts,
albeit their amount was lower on 1 M than on 0.5 M KCl capsids.
and tau (B: pAb). The amount of capsids in each sample was estimated by labeling the major capsid proteins VP26 (A: pAb anti-VP26), VP5 (B: pAb NC-
1), or VP19c (B: pAb NC-2). As a loading control, 7% of the amount of the input cytosol was also directly analyzed (B; lane 8). C: Immunoelectron
microscopy images of HSV1(F) capsids incubated with 0.75 mg/ml pig brain cytosol and labeled with mouse monoclonal antibodies against dynein
(MAB1618 against intermediate chain), dynactin (mAb anti-p50), kinesin-1 (MAB1613 against heavy chain) or kinesin-2 (mAb K2.4 against KIF3A)
followed by rabbit-anti-mouse antibodies, protein-A gold and negative staining. Scale bar: 50 nm. D: Quantification of the labeling intensity of
different capsid types. After immunogold-labeling with antibodies against MAPs, negative staining and electron microscopy, the number of gold
particles per capsid was counted for 100 to 170 capsids. Labeling of capsids incubated with buffer instead of cytosol was considered background and
subtracted. Error bars: SEM. Three asterisks denote P,0.0001 as determined in a two-sided Student’s t-test. E: Labeling frequency for different MAPs
on individual viral capsid treated with 0.5 M KCl. In a two-dimensional projection, the icosahedral capsid appears as a hexagon that can be divided
into 6 segments (c.f. C; schematic capsid). The number of capsids that had labeling on 0, 1, 2, or more of such segments was counted. Gold particles
were counted as multiple labeling events when they were more than 40 nm apart (C; circles on schematic capsid). Labels in closer proximity were
scored as only one label (C; stars on schematic capsid). Error bars: SEM. The quantifications (D, E) were compiled from three experiments analyzing
dynein, dynactin and kinesin-1 and two experiments for kinesin-2.
doi:10.1371/journal.ppat.1000991.g002
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PLoS Pathogens | www.plospathogens.org 7 July 2010 | Volume 6 | Issue 7 | e1000991Figure 3. Characterization of tegumented, viral HSV1 capsids. The MAP binding (Fig. 2; left 4 data sets) to the three viral capsid types treated
with 0.1, 0.5 or 1 M KCl (panels A, B and C, respectively) and their inner (middle 8 data sets) and outer tegument (right 8 data sets) organization
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The immunoblot and mass spectrometry analysis demonstrated
that increasing KCl from 0.1 to 0.5 M extracted several tegument
proteins from viral capsids, and thus presumably improved the
accessibility of inner tegument structures (Fig. 3 and Supplemen-
tary Table S1). Capsids treated with 0.5 M or 1 M KCl had
qualitatively similar, although quantitatively distinct, protein
compositions, but differed substantially in recruiting kinesin-1.
We wondered whether increasing to 1 M KCl might denature
epitopes of the inner tegument without removing further proteins,
and therefore examined the capsid surfaces by immunoelectron
microscopy using various anti-HSV1 antibodies (Fig. 8A). All
capsids were prominently labeled by antibodies directed against
the major capsid protein VP5, whereas pUL6, the portal for DNA
packaging [56] was detected at just one corner of the hexagonal
capsid. For further assessment, we set after background subtrac-
tion the accessibility of given tegument epitopes on the capsids
with the highest amount to 100%, and recalculated the other data
(Figs. 6,7,8) have been analyzed by immunoblot (IB), quantitative mass spectrometry (MS), and quantitative immunoelectron microscopy (IEM). While
IB and MS indicate the amount of different tegument proteins on the capsids, the IEM determines to what extent such tegument proteins were
accessible on the capsid surfaces to antibodies or host factors. Please note that nuclear capsids did not bind to MAPs and contained very little
tegument (c.f. Figs. 2, 6, 7, 8; data not shown in this figure). For further comparative analysis, we normalized the results of the IB, MS and IEM for the
viral capsids such that the amount of a given MAP or a tegument protein on the capsids with the highest amount was set to 100%, and recalculated
accordingly for the other capsid types (% of highest). These results are also listed in supplementary Table S1. Please note that in contrast to MS and
IEM, the IB data were not quantitative. Instead, we only estimated the amount of the respective proteins based on the band intensities into 4 classes:
absent (0%), minor (33%), major (66%) or highest (100%) amounts.
doi:10.1371/journal.ppat.1000991.g003
Figure 4. Dynein, dynactin, and kinesin-1 bind directly to tegumented HSV1 capsids. HSV1 (F) capsids binding do dynein and or dynactin
(A) or kinesin-1 (B) was analyzed as follows: HSV1(F) capsids generated by detergent lysis of extracellular virions in the presence of 0.5 M KCl, or
nuclear C capsids were incubated with buffer (A: lane 1), 0.25 mg/ml pig brain cytosol (A: lanes 2 and 3), 15 mg/ml purified, native dynein (A: lanes 4
and 5), 15 mg/ml purified, native dynactin (A: lanes 6 and 7) or native dynein and dynactin (A: lanes 8 and 9) or with buffer (B: lane 5), 0.75 mg/ml pig
brain cytosol (B: lanes 6 and 7) or 33 mg/ml purified, native kinesin-1 (B: lanes 8 and 9), and sedimented through a sucrose cushion. As controls,
cytosol (B: lanes 1 and 3) or purified kinesin-1 (B: lanes 2 and 4) were also directly analyzed (B: lanes 1 and 2) or sedimented in the absence of capsids
(B: lanes 3 and 4). Host proteins were detected by immunoblotting with antibodies against dynein (A & B: MAB1618 against intermediate chain),
dynactin (A: mAb anti-p150, mAb anti-p50, B: anti-CapZb mAb3F2.3), kinesin-1 (B: MAB1613 against heavy chain, MAB1616 against light chain),
kinesin-2 (B: mAb against KAP3A). As loading controls, the samples were probed with antibodies against the capsid proteins VP5 (A and B: pAb NC-1)
or VP19c (A and B: pAb NC-2). These blots show one of three independent experiments yielding similar results.
doi:10.1371/journal.ppat.1000991.g004
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PLoS Pathogens | www.plospathogens.org 9 July 2010 | Volume 6 | Issue 7 | e1000991Figure 5. MAPs bind to HSV1 capsids lacking VP26, pUS11, or VP11/12. Capsids of HSV1(KOS)-DVP26 (A: lanes 3 to 5), HSV1(F)-DUS11 (B:
lanes 3 to 5), or HSV1(F)-DVP11/12 (C: lanes 3 to 5) were isolated by detergent lysis of trypsin-treated extracellular virions in the presence of 0.5 M KCl
or from nuclei of infected cells (C capsids). HSV1(F) wild-type was used as control (A, B, C: wt, lanes 6 to 8). The capsids were incubated in 0.75 mg/ml
pig brain cytosol, and after sedimentation analyzed by immunoblot with antibodies against dynein (A, B, C: MAB1618 against intermediate chain; A:
pAb anti-LIC2 against light intermediate chain), dynactin (A, B: mAb anti-p50; A, C: mAb3F2.3 against CapZb), or kinesin-1 (A, B, C: MAB1613 against
heavy chain). Labeling with antibodies against VP26 (A: pAb anti-VP26) or pUS11 (B: mAb #28) confirmed the lack of these proteins on mutant
capsids. As loading control, the samples were probed with antibodies against the capsid protein VP5 (A, B, C: pAB NC-1). As controls, cytosol alone
was directly analyzed (A, B, C: lanes 1) or sedimented in the absence of capsids (A, B, C: lanes 2). These blots show one of two or more experiments
yielding similar results.
doi:10.1371/journal.ppat.1000991.g005
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S1). Due to lack of suitable antibodies to pUL37, we also used
HSV1 with a green fluorescent protein (GFP)-tagged pUL37 and
an antibody directed against GFP.
The inner tegument proteins pUS3, pUL36 or pUL37GFP
were not restricted to vertices. pUS3 was detected on all capsid
types, but was much more abundant on viral than on nuclear
capsids (Fig. 8B). While immunoblot and mass spectrometry
analysis (Fig. 6B & 7B) showed similar amounts of pUL36 and the
N-terminal pUL36 fragment on viral capsids, the immunoelectron
microscopy revealed differences in pUL36 surface exposure. An
antibody raised against a middle portion of pUL36 (residues 1408–
2112) that detects numerous forms of pUL36 by immunoblot
(Fig. 6B), showed a similar surface exposure of pUL36 (M-pUL36;
Fig. 8A,B) on viral capsids with the highest signal on 0.5 M KCl
capsids. In contrast, an antibody generated against a C-terminal
peptide of pUL36 (residues 3048–3057; [57]) revealed the
strongest signal on 0.5 M KCl capsids and an intermediate one
on 0.1 M KCl capsids, but did not label 1 M KCl capsids at all
(Fig. 8B). Interestingly, nuclear capsids were also labeled by this
antibody, but lacked epitopes of the middle portion of pUL36.
These results suggest that only a C-terminal fragment of pUL36
was associated with nuclear capsids. Similar to pUL36, surface
exposure of pUL37GFP was highest on 0.1 and 0.5 M, reduced to
25% on 1 M KCl, and absent on nuclear capsids (Fig. 8B).
For comparison, we also determined the labeling efficiency for
the outer tegument proteins VP16, VP13/14 and VP22 that were
detected best on the surface of 0.1 M KCl capsids, and reduced on
0.5, 1 M and nuclear capsids (Fig. 8C). Of those, the VP22
epitopes showed the strongest difference between 0.5 and 1 M KCl
capsids. Together with the immunoblot and mass spectrometry
analysis, these immunoelectron microscopy-labeling patterns were
most consistent with a gradual removal of the major tegument
proteins from viral capsids (c.f. Fig. 3). In contrast, the minor
capsid protein pUL25 was at the vertices of all viral capsids and C
capsids in similar amounts, but reduced on B capsids (Fig. 8D).
These results suggest that the asymmetric tegument cap [26] did
not tightly cover the entire capsid surface, since it did not prevent
access of antibodies, and presumably also not of host proteins to
major capsid proteins.
In summary, increasing the salt concentration resulted in an
increased removal of outer tegument proteins and destroyed
epitopes of the inner tegument proteins pUL36 and pUL37GFP,
although these proteins were still detected on 1 M KCl capsids by
immunoblot and mass spectrometry analysis (Fig. 3). C-terminal
epitopes or fragments of pUL36 that were detected on nuclear
capsids were also denatured or even dissociated from 1 M KCl
capsids. Thus, the surface analysis by immunoelectron microscopy
revealed clear differences between 0.5 and 1 M KCl capsids that
had remained elusive by immunoblot or mass spectrometry
Figure 6. Immunoblot characterization of nuclear and viral
HSV1 capsids. The protein composition of HSV1 capsids (nuclear B
capsids, nuclear C capsids, viral capsids treated with 1.0, 0.5 or 0.1 M
KCl), virions sedimented from cell culture supernatants (MP, medium
pellet) and gradient purified virions (GP) were analyzed by immunoblot
using antibodies directed against the capsid proteins VP5 (A–E: pAb NC-
1), VP26 (A–E: pAb anti-VP26), VP19c (A: pAb NC-2), pUL17 (B: mAb
#203), pUL25 (C: pAb ID1), pUL16 (D: anti-pUL16), or the tegument
proteins pUS3 (A: pAb anti-pUS3), pUL37 (A: pAb 780), VP22 (A: pAb
AGV30), pUS11 (A: mAb #28), pUL36 (B: pAb #147; anti-middle-pUL36),
pUL11 (B: pAb anti-pUL11), ICPO (C: mAb 11060), pUL14 (D: anti-pUL14),
vhs (D: pAb 11.388), VP13/14 (D: pAb R220), ICP4 (E: mAb 58S), ICP34.5
(E: pAb anti-ICP34.5) and VP16 (E: pAb SW7). Each blot shows one of
three indendent experiments. The panels A, B, C, D, and E represent
separate membranes. These data were after a further normalization also
integrated into Fig. 3 (white columns).
doi:10.1371/journal.ppat.1000991.g006
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PLoS Pathogens | www.plospathogens.org 11 July 2010 | Volume 6 | Issue 7 | e1000991Figure 7. Mass spectrometric characterization of nuclear and viral HSV1 capsids. The protein composition of HSV1 capsids (B: nuclear B
capsids, viral capsids treated with 1.0, 0.5 or 0.1 M KCl), virions sedimented from cell culture supernatants (MP, medium pellet) and gradient purified
virions (GP) were analyzed by quantitative mass spectrometry. A: the capsid proteins VP5, VP26, VP19c, VP23, VP24, B: the capsid-associated proteins
pUL17 and pUL25 and the inner tegument proteins pUL36, an N-terminal fragment of pUL36, pUL37, pUL16, pUL21 and C: the other tegument
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inner tegument layer that abrogated kinesin-1, but not dynein or
dynactin recruitment.
Discussion
We used five different capsid types and mammalian brain
cytosol to analyze the interaction of HSV1 capsids with host MT
motors. Starting with nuclei of infected cells or extracellular
virions, and varying the salt concentration during virion lysis, we
generated capsids with different protein composition and different
surface features without impairing their overall architecture. Using
immunoblot and quantitative immunoelectron microscopy, we
show that dynein, dynactin, kinesin-1 and kinesin-2 bound
specifically to viral capsids, but not to nuclear capsids (summarized
in Fig. 3 & 9). Presumably, entire MAP complexes, and not just
individual subunits, associated with the viral capsids, since we
could detect several subunits of each MAP. In contrast, GST or
other cytosolic host proteins such as tau, amphiphysin or LC3
were not recruited.
Dynein colocalizes with inbound cytosolic HSV1 capsids
[33,34]. Furthermore, outbound capsids might use dynein for
transport to the trans-Golgi network, where HSV1 capsids acquire
their final envelope [4,30,37,38,39; Do ¨hner, Sodeik & Bauerfeind,
unpublished observations]. Our experiments with purified motors
showed that dynein can bind directly - independent of other host
factors - to tegumented capsids. Similarly dynactin also bound
directly and independently of other host factors to viral capsids.
This is different from many host cargos that utilize dynactin as an
adaptor to recruit dynein [16,18,58]. However, destroying the
dynactin complex by an artificial excess of its subunit dynamitin
reduces nuclear targeting of HSV1 capsids in vivo as well as the
number of motile capsids and the transport velocity in vitro [23,34].
Thus, dynactin may rather enhance dynein processivity than
function as an adaptor to recruit dynein onto capsids, as has also
been described for some host cargos [16,18,58].
Dynactin also enhances the processivity of kinesin-2,i ti sa
cofactor for both, dynein and kinesin-2 mediated transport of
Xenopus melanosomes, and it interacts directly with kinesin-2
[59,60]. KIF3A, one of the heavy chains of kinesin-2, interacts
with pORF45, a tegument protein of the gammaherpesvirus
KSHV that has no homolog in alphaherpesviruses. Inhibition of
kinesin-2 activity by siRNA gene silencing reduces viral yields of
KSHV in lymphoma cells, but not of HSV1 in epithelial cells [61].
Thus, so far, there is no evidence of a role for kinesin-2 in the life
cycle of alphaherpesviruses. Nevertheless, tegumented, but not
nuclear HSV1 capsids specifically recruited kinesin-2, either
directly via a tegument protein or via its interaction with dynactin
or another host factor (Fig. 9). Kinesin-2 may either facilitate
intracellular transport in epithelial cells in a non-essential manner,
or catalyze axonal transport of outbound particles in neurons.
Kinesin-1 also bound directly in the absence of other host
factors to 0.5 M KCl capsids. This differs from many membranous
host cargos that recruit kinesin-1 via adaptors such as huntingtin-
associated protein 1, sunday driver or amyloid precursor protein
[9,62,63]. However, in contrast to tubulin and several proteins of
the actin cytoskeleton, such adaptors or other MAP subunits have
not been detected in purified herpesvirus particles [20,64].
Kinesin-1 may catalyze HSV1 capsid transport from the MTOC
to the nucleus, it colocalizes with outbound HSV1 particles in
axons, and it may mediate axonal transport of progeny cytosolic
capsids [4,40,49]. Inhibiting kinesin-1 but not kinesin-2 by siRNA
gene silencing or overexpression of dominant-negative protein
domains reduced nuclear targeting of inbound HSV1 capsids in
epithelial cells (Janus & Sodeik, in preparation).
The number of MT motors is unknown for viral cargos, but
on host cargos ranges from 2 to 10 or even more [reviewed in
7,65]. Just one dynein or kinesin-1 motor is sufficient to transport
synthetic beads over long distances in vitro, whereas at high dynein-
dynactin concentrations such beads stall at MT intersections [66].
Cargo driven by too many motors seems more likely to get trapped
in a fruitless tug-of-war between motors interacting with different
MTs. Each reaction contained viral capsids derived from 5610
8
PFU/60 mL with about 10 to 60 DNAse protected genomes/PFU
[42]. Taking this number of genomes as the lowest estimate, the
viral capsids were within a concentration of 0.1 to 0.8 nM. Based
on immunoblots and comparing with protein concentrations of the
MAP preparations, we estimate that our cytosolic extracts contain
about 30 nM dynein, 40 nM dynactin, and 190 nM kinesin-1.
Thus, there were about 35 to 300 molecules dynein, 50 to 400
molecules dynactin, and 240 to 1900 molecules of kinesin-1
present per capsid. Compared to the cytosol loading control, about
1 to 20% of the total MAPs were co-sedimented with viral capsids
treated with 0.5 M KCl. These rough estimations suggest that in
our assays, a capsid recruited 0.3 to 60 copies of dynein, 0.5 to 80
copies of dynactin, and 2.5 to 380 copies of kinesin-1.
On thawed cryosections of cells, protein-A gold labels antibodies
directed against dynein on about 13% of inbound cytosolic HSV1
capsids [33]. The labeling efficiency for this technique is estimated
to detect 5 to 10% of the antigens present [47,67]. Thus, it seems
reasonable to assume that, in cells, all incoming capsids are
associated with dynein. Here we labeled for host factors bound to
capsids in vitro which should be even better accessible to antibodies,
although the antibodies and protein-A gold may still preferentially
label the apical capsid surfaces over those facing the substrate. Our
immunoelectron microscopy demonstrated that at least 20% of the
capsids accommodated more than one copy of dynein, and about
10% more than one dynactin or kinesin-1 complex.
Since dynein and dynactin, but not kinesin-1, bound to 1 M
KCl capsids (Fig. 3, Supplementary Table S1), and given that
purified dynein and dynactin bound independently of each other,
these 3 MAPs seem to associate with different surface features or
domains on 0.5 M KCl capsids. As nuclear capsids did not bind
MAPs, the tegument and not the capsid proteins must contain the
viral receptors for microtubule motors. Capsids derived
from HSV1 knock-out strains showed that VP26, pUS11 or
VP11/12 do not contribute to the generation of the viral motor
receptors that we analyzed here. Furthermore, PrV does not
encode a homolog of US11, and HSV1 mutants lacking VP26 or
pUS11, as well as PrV lacking VP26, pUL14, VP11/12 or VP22
are not impaired in nuclear targeting of capsids [42,68,69; Janus &
Sodeik, in preparation]. Thus, these viral proteins are less likely to
contribute to the generation of viral motor binding domains.
proteins pUL16, pUL21, VP13/14, VP16, VP22 and VP11/12 were analyzed. The relative protein amount in a capsid or a virus preparation is given in
comparison to the gradient purified virions set as 100%. Values lower than 100% indicate removal of a protein in the respective capsid or virus
preparation, whereas values higher than 100% indicate a higher amount of this protein in capsid samples than in gradient purified virions. Values are
normalized to the amount of the capsid protein VP5 to account for varying amounts of capsids in each sample. Mean values of three independent
experiments are given for viral capsids treated with 1, 0.5 and 0.1 M KCl, and one experiment for medium pellet and nuclear B capsids. Error bars: SD.
These data were after a further normalization also integrated into Fig. 3 (green columns).
doi:10.1371/journal.ppat.1000991.g007
HSV1 Capsid Binding to Microtubule Motors
PLoS Pathogens | www.plospathogens.org 13 July 2010 | Volume 6 | Issue 7 | e1000991Figure 8. Generation of different HSV1 capsid surfaces during isolation. HSV1(F) capsids were isolated from infected nuclei (B or C) or
prepared from extracellular virions by detergent lysis in the presence of different KCL concentrations (1, 0.5 or 0.1 M KCl), and labeled with antibodies
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VP11/12 bound even more MAPs than wild-type. As dynein,
dynactin, kinesin-1 or kinesin-2 are not present in complete virions
[64], the acquisition of outer tegument proteins during assembly
may gradually compete for MAP binding. Since outer tegument
proteins associate with viral envelope proteins [30,37], MAPs may
even need to dissociate prior to secondary envelopment. A reverse
reaction seems to occur during cell entry. Upon viral fusion, the
bulk of tegument proteins detaches from incoming HSV1 and PrV
capsids and remains bound to the viral envelope, thereby exposing
the underlying capsid-associated inner tegument proteins
[26,33,70,71,72]. We suppose that treating virions with TX-100
and 0.5 M KCl results in a similar separation of the outer from the
inner tegument layer, and thus enables access of cytosolic host
factors to capsid-associated viral motor receptors. This notion is
supported by the low binding of MAPs to capsids treated with 0.1
M KCl that still contain high amounts of the tegument proteins
vhs, pUL11, ICP4, ICP34.5, VP11/12, VP13/14, VP16, and
VP22. We therefore classified proteins that were abundant on 0.1
M capsids, but reduced by treatment with 0.5 or 1.0 M KCl as
outer tegument proteins (Fig. 3; Supplementary Table S1). This
outer tegument rather prevented than mediated a recruitment of
MT motors to herpesvirus capsids.
The 0.1 and 0.5 M KCl treated capsids contained other proteins
in similar amounts that we consider inner tegument components:
pUS3, pUL36, pUL37, ICP0, pUL14, pUL16, and pUL21 (Fig. 3,
Supplementary Table S1). While pUL21 is not required for
retrograde spread of PrV, the tegument is not properly assembled
in a PrV mutant lacking UL21 [69,73,74]. Thus, binding assays
using capsids derived from such mutants alone would not suffice to
demonstrate that pUL21 acts as a viral receptor for motors.
pUL36, pUL37, or pUL21 may interact with kinesin-1 or at least
contribute to the formation of a viral kinesin-1 receptor, since
these proteins were reduced or at least some of their epitopes were
denatured by treating viral capsids with 1 M KCl (Fig. 3,
Supplementary Table S1).
Considering all HSV1 structural proteins, pUL36 and pUL37
are likely candidates to either directly enlist motors to capsids, or
to recruit other tegument proteins that function as viral motor
receptors. pUL37 interacts directly with the capsid protein VP26,
and with pUL36 that is linked via pUL25 to capsids [75,76,77].
pUS3, pUL36, and pUL37GFP remain associated with incoming
capsids during nuclear targeting; and HSV1 and PrV mutants
lacking pUL36 or pUL37 are impaired in intracellular transport
[43,69,71,78,79,80,81,82,83; Schipke & Sodeik, in preparation].
We show here that pUL36 and pUL37GFP were exposed on the
surface of 0.5 M KCl treated capsids, and that epitopes of pUL36
and pUL37 were altered by increasing KCl concentration from
0.5 to 1 M which also inactivated the receptor binding site for
kinesin-1 (Fig. 3, Supplementary Table S1).
Unfortunately, capsids of HSV1 or PrV mutants lacking pUL36
or pUL37 cannot be isolated from extracellular virions, since
cytosolic capsids are not enveloped, and no virions are assembled
[43,78,79]. Therefore, binding assays with capsids derived from
such mutants require new purification protocols to isolate
sufficient amounts of cytosolic progeny capsids not contaminated
by the more abundant nuclear capsids [43]. Considering the
multivalent interactions among several tegument proteins
[30,37,77], the lack of pUL36 or pUL37 may result in an altered
tegument organization, as has already been shown for mutants
lacking pUL21 [69,73,74]. Future binding studies with such
mutant capsids will therefore require a thorough investigation of
their molecular tegument architecture.
The capsid transport direction to the cell center or
periphery during cell entry and egress must be regulated. Our
data suggest that dynein and kinesin-1 bind to distinct surface
features on 0.5 M KCl capsids, since treatment with 1 M KCl
specifically inactivated kinesin-1 but not dynein binding. A similar
modification of the tegument surface may also occur in vivo and
change the affinity of capsids for motors, e.g. during cell entry
when pUL36 is cleaved, or tegument proteins are phosphorylated
[70,84]. Thus, an ‘‘exclusive’’ presence of either minus- or plus-
against the capsid proteins VP5 (A: pAb NC-1), pUL25 (A, D: pAb ID1) or pUL6 (A: mAb 1C), against the inner tegument proteins pUS3, (A: pAb anti-
US3), pUL36 (A, B: pAb #147, anti-middle-pUL36; B: pAb anti-Cterminal-pUL36), pUL37-GFP (B: mAb anti-GFP JL-8; here capsids from strain HSV1-
pUL37GFP), or the outer tegument proteins VP13/14 (C: pAb R220), VP16 (D: pAb SW7), or VP22 (D: pAb AGV30). A: Immunoelectron microscopy
images of capsids after immunolabeling followed by protein-A gold and negative staining. Scale bar: 50 nm. Bt oD : The labeling intensity for inner
tegument proteins (B), outer tegument proteins (C) or the capsid associated protein pUL25 (D) was quantified by counting the number of gold
particles per capsid. After subtraction of the background without the primary antibodies, the number on the capsid type with the highest labeling
was set to 100%, and recalculated accordingly for the other capsid types. These data sets were also directly integrated into Fig. 3 (red columns). Error
bars: SEM. n: number of capsids (same for each capsid type with a given antibody) summarized from three experiments. Two asterisks denote
p,0.001 and three asterisks indicate P,0.0001 as determined in two-sided Student’s t-tests.
doi:10.1371/journal.ppat.1000991.g008
Figure 9. Scale drawing of a HSV1 viral capsids exposing inner
tegument proteins and interacting with MAPs. Tegumented
(light green) HSV1 capsid (dark green) with three bound dynein
(orange), three dynactin (yellow), five kinesin-1 (dark blue) and 3
kinesin-2 (light blue). The scheme has been drawn to scale and
assuming that MT binding domains of the MAPs point away from the
capsid to enable microtubule binding. Dynein, dynactin and kinesin-1
can interact directly and independently of each other with the capsids.
Individual capsids could recruit several copies of a MAP, and different
MAPs at once. Dynein and Kinesin-2 may either bind directly to
tegument proteins or indirectly via dynactin. Furthermore, kinesin-2
may also utilize another, unknown host factor (X). Scale bar: 50 nm.
doi:10.1371/journal.ppat.1000991.g009
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composition may regulate their transport direction [8], while such
a mechanism seems to be less used for host cargos [6,7,9,85].
Time-lapse microscopy shows that HSV1 and PrV particles
quickly change transport directions in vivo suggesting that motors of
opposing directionality are present simultaneously on viral
particles. Nuclear targeting of inbound and egress of outbound
PrV particles can occur simultaneously within the same cell,
suggesting that there is no overall inhibition or stimulation of host
factors controlling transport direction during herpesvirus infection
[32]. However, in many live cell microscopy experiments,
transport of cytosolic capsids cannot be distinguished from
transport of virions within host membranes [31,32,86; Janus &
Sodeik, in preparation].
Our biochemical single-particle analysis shows that at least 10%
of all capsids had bound the both motors dynein and kinesin-1
simultaneously. Thus, it seems likely that also in cells individual
cytosolic capsids can recruit the entire transport machinery of
dynein, dynactin, and kinesin-1 (Fig. 9). Therefore, the transport
direction of HSV1 capsids does not seem to be regulated by an
exclusive presence of either plus- or minus-end directed motors.
The bound motors rather either engage in a tug-of-war to
determine the direction of net transport, or the activities of the
bound motors are coordinately regulated. For example, an
alternating activation of either plus- or minus-end directed motors
e.g. by host or viral kinases or binding of cellular inhibitors could
mediate fast changes in transport direction.
Future studies with such biochemical assays will provide
further insights into the regulation of essential virus-host
interactions, for example by adding, depleting, or inhibiting
specific host factors such as kinases. Furthermore, the functions of
structural viral proteins can be elucidated even if their mutation
prevents virus formation or cell culture models are lacking.
Recombinant proteins, protein fragments, or peptides derived
from viral genes can be tested for their ability to compete with
particle-associated viral proteins for the recruitment of host factors.
Such assays will identify viral structures that are required for
motor binding and capsid nuclear targeting, and that therefore
should be maintained in viral gene therapy vectors. These
structural features or domains may even be added to artificial
nano carriers or other vectors to be exploited for human
therapeutic gene and cell therapy.
Materials and Methods
Viruses, cells and antibodies
HSV1 strains F (ATCC VR-733), 17
+ [87], HSV1(KOS)-
DVP26 (HSV1-Kdelta26Z; from Prashant Desai, Johns Hopkins
University, Baltimore, USA; [68]), HSV1(F)-DUS11 (HSV1-G6/
166; from Richard Roller, University of Iowa, Iowa, USA; Janus &
Sodeik, in preparation), HSV1(F)-DVP11/12 (R[F] UL46D3.1;
from Jennifer L.C. Mc Knight & Tom Kristie, NIH, Bethesda,
USA; [88,89]), and HSV1(17
+)-pUL37GFP (from Frazer Rixon,
MRC Virology Unit, Glasgow, UK; [90]) were propagated in
BHK-21 and titrated on Vero cells [42]. Antibodies directed
against viral or host proteins are listed in the supplement (Tables
S2, S3).
Viral capsids
Particles sedimented from the medium of infected cells,
corresponding to approximately 5610
8 PFU of HSV1, were left
untreated, or incubated with 0.5 mg/ml trypsin (Sigma-Aldrich,
Germany) at 37uC for 1 h and with 5 mg/ml trypsin inhibitor
from soybean (Fluka, Switzerland) for 5 min on ice. Virions were
lysed for 30 min on ice by adding an equal volume of twofold lysis
buffer (2% TX-100, 20 mM MES, 30 mM Tris, pH 7.4, 20 mM
DTT, 20 mg/ml antipain, 4 mg/ml bestatin, 4 mg/ml pepstatin,
4 mg/ml aprotinin, 20 mg/ml E-64, 4 mg/ml leupeptin, 320 mg/ml
phenylmethylsulfonylfluoride) containing KCl to achieve final
concentrations of 0.1 M, 0.5 M or 1 M.
Capsids were separated from solubilized membrane and
tegument proteins by layering the extract on top of a 20% (w/v)
sucrose cushion in 30 mM MES and 20 mM Tris, pH 7.4 with
10 mM DTT, protease inhibitors as above and the respective KCl
concentrations and sedimentation at 50 krpm for 15 min at 4uCi n
a TLA100.2 Beckman rotor. Supernatants and cushions were
carefully removed, and the pellets were resuspended in BRB80
(80 mM PIPES, pH 6.8, 12 mM MgCl2, 1 mM EGTA) with
10 mM DTT, protease inhibitors including 1 mg/ml soybean
trypsin inhibitor and 0.1 U/ml protease-free DNase I (Promega,
USA) and 100 mg/ml protease-free RNase (Roth GmbH,
Germany). After incubation for 30 min at 37uC and over night
at 4uC, capsids were repelleted for 8 min at 50 krpm in a
TLA100.2 rotor at 4uC, and resuspended in cytosol or buffer by
tip sonification on ice 3 times for about 10 seconds at 40 W.
Nuclear capsids
BHK-21 cells were infected with 0.01 to 0.02 PFU/cell for 2 to
3 days until the cells detached from culture flasks. Infected cells
were collected by sedimentation, washed once with MNT buffer
(30 mM MES, 20 mM Tris, pH 7.4, 100 mM NaCl), snap frozen
and stored at 280uC. Nuclear capsids were prepared as described
previously [23,91], diluted in three volumes TNE (20 mM Tris,
pH 7.5, 500 mM NaCl, 1 mM EDTA) with 10 mM DTT and
protease inhibitors, and sedimented in BSA-coated centrifuge
tubes at 50 krpm in a Beckman TLA100.2 rotor at 4uC for
15 min. The pellets were resuspended in BRB80 buffer with
10 mM DTT, 1 mg/ml soybean trypsin inhibitor, protease
inhibitors, 100 mg/ml RNase (Roth, Germany) and 0.1 U/ml
DNase I (M6101, Promega, USA) and treated as described for
viral capsids.
Cytosol and microtubule motors
Pig brain cytosol was prepared according to [92]. Brains of
Pieton pig were homogenized in one volume extraction buffer
(50 mM PIPES, 50 mM HEPES, pH 7.0, 2 mM MgCl2,1m M
EDTA) with 1 mM DTT and protease inhibitors with a Potter-
Elvejehm homogenizer. Cellular debris was sedimented at
24,000 g for 30 min at 4uC, and the supernatant was snap-frozen
in liquid nitrogen and stored at 280uC. Directly prior to binding
experiments, 1/20 volume of an ATP-regenerating system
(150 mM creatine phosphate, 20 mM ATP, 20 mM MgCl2,
2 mM EGTA, pH 7.7) was added to the extracts to induce release
of membrane-bound motors [93]. After sedimentation of mem-
branes at 55 krpm and 4uC for 30 min in a TLA100 rotor, the
membrane-free supernatant containing soluble cytosolic factors
was collected. After addition of 10 U/ml apyrase (Sigma-Aldrich,
Germany), and incubation at room temperature for 10 min to
deplete endogenous ATP, the cytosol was diluted in acetate buffer
(10 mM PIPES, pH 7.4, 100 mM potassium acetate, 3 mM
magnesium acetate, 5 mM EGTA) with 5% (w/w) sucrose,
1 mg/ml BSA, 10 mM DTT, 50 mM nocodazole and protease
inhibitors. Cytosolic extracts prepared by this protocol were
devoid of membranes, and thus of cellular transport vesicles (Fig.
S2). Dynein and dynactin were purified from bovine brain [94]
and kinesin-1 from pig brain [95], and the purity of the these
preparations were confirmed by SDS-PAGE (not shown).
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Viral capsids or nuclear capsids were resuspended in 60 ml
cytosol (0.25 mg/ml protein for dynein and dynactin, 0.75 mg/ml
for kinesin-1 and kinesin-2) or buffer. After 1 h incubation at 0uC
(Fig. 2 & 4A) or 37uC (Fig. S1, 4B, 5), the capsids were either
sedimented through a 30% (w/v) sucrose cushion in acetate buffer
by centrifugation at 50 krpm for 15 min in a Beckman TLA100
rotor, or directly subjected to immunogold-labeling and electron
microscopy. Pellets were washed once in acetate buffer, spun for
8 min at 50 krpm in a TLA100 rotor and analyzed by SDS-PAGE
and immunoblotting. Controls lacking cytosol revealed some but
not all preparations of viral capsids already contained dynein and
dynactin in varying amounts (Fig. S1B, compare lane 1 with lane
3). To remove such host factors, we first incubated the
extracellular particles with trypsin (Fig. S1A). After adding trypsin
inhibitor and lysis buffer, we then isolated viral capsids. A large
fraction of the major capsid proteins VP5, VP19c and the
tegument protein VP13/14 was protected by the viral membrane
of intact virions, and protected from tryptic cleavage (Fig. S1B,
compare lane 2 and 4). Such capsids contained little dynein and
dynactin (Fig. S1B, lane 8), but were still able to recruit new MAPs
from the cytosol (Fig. S1B, lane 10). Without viral capsids, MAPs
by themselves did not sediment (Fig. S1B, lanes 5 and 6).
SDS-PAGE and immunoblot
Protein samples were separated on linear 7.5 to 18% or 5 to
15% SDS-PAGE, transferred onto nitrocellulose membrane (Pall
Corporation, USA) and detected using specific primary antibodies
(c.f. Tables S2,S3) and secondary antibodies coupled to horse-
radish peroxidase (Dianova or Pierce-Perbio Science, Germany)
for ECL detection (SuperSignal West Femto Maximum Sensitivity
Substrate, Pierce, Germany).
Negative staining and immunoelectron microscopy
After adsorption on 400 mesh formvar- and carbon-coated
copper grids (Stork Veco, The Netherlands) and blocking
unspecific protein binding sites with 10 mg/ml BSA in PBS, the
samples were labeled with primary mouse antibodies and rabbit
anti-mouse IgG (Cappel
TM, MP Biomedicals, USA) or just with
primary rabbit antibodies followed by protein-A gold (10 nm; Cell
Microscopy Center, Utrecht School of Medicine, The Nether-
lands). After washing with PBS and distilled water, preparations
were negatively contrasted using 2% (w/v) uranyl acetate (Merck,
Germany), and analyzed with an EM10CR transmission electron
microscope (Carl Zeiss AG, Germany) at 80 kV. For quantifica-
tion of MAPs bound to capsids, samples were prepared from
capsids incubated with cytosol or with buffer as a negative control.
The number of gold particles per capsid incubated with buffer was
considered background labeling and subtracted from the labeling
on capsids that had been incubated with cytosol. For analysis of
viral proteins, a similar background subtraction was performed
with capsids labeled in the absence of a primary antibody.
Background labeling was similar in both approaches and ranged
from 0.3–0.5 gold/capsid without cytosol and 0.3–0.7 gold/capsid
without a primary antibody. For negative staining without
labeling, grids with adsorbed virus particles were washed three
times with PBS, incubated in distilled water for 10 min, washed in
distilled water and negatively contrasted by incubation with 10 ml
2% (w/v) uranyl acetate (Merck, Germany).
Mass spectrometry
SILAC was performed with slight modifications as described
previously [51]. BHK-21 cells were cultured for three passages in
DME-nutrient mixture F12 Ham medium (Sigma-Aldrich D-
9785) supplemented with 5% (v/v) dialyzed FCS and either
deuterated (L-leucine-5,5,5 d3; Sigma-Aldrich; 99 atom% D) or
conventional protonated L-leucine. The isotope exchange in the
deuterated cells was confirmed by mass spectrometry. Isotope
labeled cells and media were then used to prepare deuterated and
protonated virus stocks of HSV1 strain F. Deuterated virions were
further purified by sedimentation at 50,000 g for 2 h at 4uC
through a linear 10% to 40% (w/v) nycodenz gradient in MKT
buffer, and collection of the light scattering band. Protonated
virions were sedimented and protonated capsids were isolated
from them as described above. 5 mg protonated virions or capsids
and 5 mg deuterated reference virions were mixed and separated
by SDS-PAGE. After staining with Coomassie Blue, all visible
bands were processed and mass spectra were registered with an
Ultraflex MALDI-TOF (matrix-assisted laser desorption/ioniza-
tion - Time-Of-Flight) mass spectrometer with TOF/TOF option
(Bruker Daltonics, Bremen, Germany) as described in [55].
Proteins were identified by query of an in-house database
representing the proteome of HSV1 strain 17
+ as compiled from
the Uniprot database in October 2009 [96]. Proteins identified
with a significant score (95% significance level, corresponding to a
MOWSE score of 33 in the configuration used) were quantified
using the in-house software AmaDeuS [97]. A minimum of three
different peptide pairs were used for the relative quantification,
with the exception of VP26 that yielded only one leucine-
containing tryptic peptide (Table S4). Mean values of intensity
ratios of all proteins were normalized to the relative abundance of
the VP5 protein in the same sample to account for varying
amounts of capsids in each capsid preparation.
Supporting Information
Table S1 Characterization of tegumented, viral HSV1 capsids.
The MAPbinding(Fig.2) to the three viralcapsidtypes treatedwith
0.1, 0.5 or 1 M KCl and their inner and outer tegument
organization (Figs. 6,7,8) have been analyzed by immunoblot (IB),
quantitative mass spectrometry (MS), and quantitative immunoe-
lectron microscopy (IEM). While IB and MS indicate the amount of
different tegument proteins on the capsids, the IEM determines to
what extend such tegument proteins were accessible on the capsid
surfaces to antibodies or host factors. Please note that nuclear
capsidsdidnotbind toMAPsand containedverylittletegument(c.f.
Figs. 2, 6, 7, 8; C capsids not shown in this table). For further
comparative analysis, we normalized the results of the IB, MS and
IEM for the viral capsids such that the amount of a given MAP or a
tegument protein on the capsids with the highest amount was set to
100%, and recalculated accordingly for the other capsid types (% of
highest). These results are also graphically displayed in Fig.3. Please
note that in contrast to MS and IEM, the IB data were not
quantitative. Instead, we estimated the amount of the respective
proteins based on the band intensities into 4 classes: absent (0),
minor (+), major (++) or highest (+++) amounts.
Found at: doi:10.1371/journal.ppat.1000991.s001 (0.11 MB
DOC)
Table S2 List of primary antibodies directed against HSV1
proteins.
Found at: doi:10.1371/journal.ppat.1000991.s002 (0.06 MB
DOC)
Table S3 List of primary antibodies directed against host
proteins or tags and secondary antibodies.
Found at: doi:10.1371/journal.ppat.1000991.s003 (0.05 MB
DOC)
HSV1 Capsid Binding to Microtubule Motors
PLoS Pathogens | www.plospathogens.org 17 July 2010 | Volume 6 | Issue 7 | e1000991Table S4 List of peptides identified by mass spectrometry. The
protein composition of HSV1 capsids, virions sedimented from cell
culture supernatants and gradient purified virions were analyzed
by quantitative mass spectrometry. Under the experimental
conditions, Mowse scores exceeding 33 are significant at the
95% level. Scores and sequence coverages of the experiment with
the highest score are given. *Calculated on basis of the full length
pUL36.
Found at: doi:10.1371/journal.ppat.1000991.s004 (0.53 MB
DOC)
Figure S1 Preparation of HSV1 capsids lacking host proteins. A.
Extracellular particle preparations contain virions (dark+light
green), light particles consisting of a membrane and tegument
but no capsid (light green), unenveloped and/or broken capsids
(dark green) with associated motors and other host cell proteins
(small, colored circles). The extracellular particles sedimented from
the medium of infected cells (MP, medium pellet) were therefore
incubated with trypsin for 1 h, and subsequently with an excess of
trypsin inhibitor to remove pre-bound host factors while protecting
viral proteins by the viral envelope. Such pretreated particles were
then lysed with a buffer containing TX-100 and different amounts
of KCl to isolate viral capsids by sedimentation through sucrose
cushions (c. f. Fig. 1). B. Immunoblot analysis of viral particles
untreated or incubated with trypsin and of their ability to recruit
MAPs. Extracellular particles of HSV1(F) corresponding to 5610
8
pfu were either left untreated in buffer (lanes 1, 3, 7, 9) or
incubated with trypsin (lanes 2, 4, 8, 10) prior to addition of trypsin
inhibitor and lysis with TX-100 in the presence of 0.5 M KCl.
Viral capsids were sedimented, incubated in buffer (lanes 1 to 4, 7,
8) or 0.75 mg/ml pig brain cytosol (lanes 9, 10), and sedimented
through sucrose cushions. The resulting pellets were analyzed by
immunoblot using antibodies against against dynein (lanes 1 to 4,
MAB1618 against intermediate chain; lanes 5 to 10, anti-LIC2
against light intermediate chain), and dynactin (lanes 1 to 4, mAb
anti-p50; lanes 5 to 10, mAb3F2.3 against CapZb). The amount of
capsids in each sample was estimated by labeling the major capsid
proteins VP5 (pAb NC-1) or VP19c (pAb NC-2) or the outer
tegument protein VP13/14 P26 (pAb R220). As controls, the
cytosol was also directly analyzed (lane 5), or sedimented in the
absence of capsids (lane 6). Please note that the two different
HSV1(F) preparations (lanes 1 and 2 versus lanes 3 and 4)
contained different amounts of pre-bound host factors (lanes 1 and
3) that could be reduced in both cases by trypsin treatment (lanes 2
and 4). A third HSV1(F) preparation (lanes 7 to 10) contained
minor amounts of pre-bound host factors that was reduced by the
trypsin treatment (compare lanes 7 with 8). The viral capsids
isolated from this trypsin-treated preparation of extracellular
particles recruited additional host factors after the incubation with
cytosol in both cases, without prior trypsin treatment (compare
lanes 7 with 9) after trypsin treatment (compare lanes 8 with 10).
These blots show one of three independent experiments yielding
similar results.
Found at: doi:10.1371/journal.ppat.1000991.s005 (1.12 MB TIF)
Figure S2 The mammalian cytosol fraction does not contain
membranes. Pig brain extract or buffer were incubated with 1 mM
DiIC18 (Molecular Probes, Eugene, USA) for 30 min at room
temperature and subsequently centrifuged as described before
(Wolfstein et al. 2006). Labeled membranes in the brain extract,
buffer as a control, the pellet and the supernatant of the
centrifugation were analyzed by fluorescence microscopy. Only
traces of membranes were detected in the cytosolic supernatant.
Found at: doi:10.1371/journal.ppat.1000991.s006 (0.18 MB TIF)
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